X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6959) 6959
Magazine Article (39) 39
Book Chapter (9) 9
Newspaper Article (8) 8
Newsletter (7) 7
Publication (2) 2
Book Review (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5510) 5510
diarrhea - chemically induced (5327) 5327
male (3800) 3800
female (3770) 3770
middle aged (2408) 2408
adult (2272) 2272
aged (2043) 2043
animals (1764) 1764
diarrhea (1714) 1714
oncology (1110) 1110
treatment outcome (974) 974
pharmacology & pharmacy (854) 854
nausea - chemically induced (818) 818
vomiting - chemically induced (801) 801
rats (697) 697
dose-response relationship, drug (659) 659
mice (626) 626
anti-bacterial agents - adverse effects (623) 623
diarrhea - drug therapy (588) 588
administration, oral (584) 584
adolescent (582) 582
chemotherapy (567) 567
antineoplastic combined chemotherapy protocols - adverse effects (564) 564
antineoplastic combined chemotherapy protocols - therapeutic use (564) 564
aged, 80 and over (563) 563
drug administration schedule (536) 536
gastroenterology & hepatology (510) 510
diarrhea - prevention & control (506) 506
time factors (505) 505
cancer (495) 495
antineoplastic agents - adverse effects (489) 489
child (446) 446
camptothecin - analogs & derivatives (412) 412
medicine, general & internal (412) 412
infant (400) 400
double-blind method (394) 394
child, preschool (387) 387
neutropenia - chemically induced (380) 380
risk factors (356) 356
therapy (339) 339
care and treatment (329) 329
research (328) 328
colitis - chemically induced (309) 309
analysis (303) 303
health aspects (303) 303
diarrhea - etiology (297) 297
neoplasms - drug therapy (297) 297
fluorouracil - administration & dosage (294) 294
toxicity (293) 293
diarrhea - microbiology (291) 291
antineoplastic agents - therapeutic use (289) 289
fluorouracil - adverse effects (285) 285
prospective studies (285) 285
colitis (281) 281
drug therapy (281) 281
irinotecan (269) 269
retrospective studies (267) 267
clinical trials as topic (265) 265
camptothecin - adverse effects (264) 264
pregnancy (264) 264
colorectal neoplasms - drug therapy (259) 259
medicine & public health (257) 257
efficacy (256) 256
research article (256) 256
double-blind (253) 253
antibiotics (252) 252
follow-up studies (245) 245
safety (244) 244
fatigue - chemically induced (239) 239
diarrhea - epidemiology (237) 237
clinical trials (236) 236
camptothecin - administration & dosage (235) 235
pharmacokinetics (235) 235
disease (234) 234
lung neoplasms - drug therapy (232) 232
young adult (230) 230
disease models, animal (227) 227
immunology (227) 227
clostridium difficile (225) 225
anti-bacterial agents - therapeutic use (223) 223
enterocolitis, pseudomembranous - chemically induced (219) 219
trial (219) 219
disease-free survival (212) 212
infectious diseases (210) 210
probiotics (207) 207
fluorouracil (202) 202
drug therapy, combination (199) 199
abridged index medicus (198) 198
prevention (198) 198
intestine (197) 197
toxicology (195) 195
patients (193) 193
infusions, intravenous (190) 190
intestinal mucosa - pathology (189) 189
intestinal mucosa - drug effects (188) 188
5-fluorouracil (185) 185
microbiology (184) 184
children (183) 183
pediatrics (183) 183
rats, wistar (183) 183
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6366) 6366
Japanese (186) 186
German (177) 177
French (164) 164
Chinese (85) 85
Spanish (68) 68
Russian (37) 37
Italian (33) 33
Polish (29) 29
Dutch (19) 19
Portuguese (16) 16
Swedish (15) 15
Norwegian (12) 12
Danish (11) 11
Hungarian (8) 8
Finnish (4) 4
Hebrew (3) 3
Slovak (3) 3
Croatian (2) 2
Serbian (2) 2
Turkish (2) 2
Bosnian (1) 1
Czech (1) 1
Korean (1) 1
Romanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CA: a cancer journal for clinicians, ISSN 0007-9235, 2013, Volume 63, Issue 4, pp. 249 - 279
Answer questions and earn CME/CNE Advances in genomics and molecular biology have identified aberrant proteins in cancer cells that are attractive targets for... 
toxicity | kinase inhibitors | therapeutic index | targeted agents | mechanism‐based toxicity | immunotherapeutic agents | off‐target toxicity | mechanism-based toxicity | off-target toxicity | MEK INHIBITOR TRAMETINIB | PULMONARY ARTERIAL-HYPERTENSION | I DOSE-ESCALATION | CHRONIC MYELOID-LEUKEMIA | GROWTH-FACTOR RECEPTOR | ONCOLOGY | PLACEBO-CONTROLLED TRIAL | III CLINICAL-TRIAL | SQUAMOUS-CELL CARCINOMAS | TIVANTINIB ARQ 197 | SIGNAL-REGULATED KINASE | Mood Disorders - chemically induced | Drug Eruptions - etiology | Peripheral Nervous System Diseases - chemically induced | Bone Marrow Diseases - chemically induced | Cachexia - chemically induced | Endocrine System Diseases - chemically induced | Pleural Effusion - chemically induced | Humans | Drug Eruptions - therapy | Immune System Diseases - chemically induced | Lung Diseases, Interstitial - chemically induced | Thrombocytopenia - chemically induced | Diarrhea - chemically induced | Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Hyperbilirubinemia - chemically induced | Venous Thromboembolism - chemically induced | Vision Disorders - chemically induced | Hemorrhage - chemically induced | Heart Diseases - chemically induced | Hyperlipidemias - chemically induced | Magnesium - blood | Antimitotic agents | Drugs | Prevention | Complications and side effects | Drug targeting | Antineoplastic agents | Health aspects | Risk factors | Proteins | Side effects | Genomics | Cytotoxicity | Molecular biology | Cancer therapies | Cells | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 770 - 778
Summary Background Pancreatic cancer statistics are dismal, with a 5-year survival of less than 10%, and more than 50% of patients presenting with metastatic... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | MITOCHONDRIAL METABOLISM | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Sulfides - administration & dosage | Pancreatic Neoplasms - drug therapy | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Hyperglycemia - chemically induced | Leucovorin - adverse effects | Fluorouracil - adverse effects | Hypokalemia - chemically induced | Camptothecin - administration & dosage | Female | Neutropenia - chemically induced | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Hematologic Diseases - chemically induced | Sensation Disorders - chemically induced | Abdominal Pain - chemically induced | Pancreatic Neoplasms - pathology | Anemia - chemically induced | Thrombocytopenia - chemically induced | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Hypoalbuminemia - chemically induced | Maximum Tolerated Dose | Sepsis - chemically induced | Sulfides - adverse effects | Aged | Caprylates - administration & dosage | Caprylates - adverse effects | Organoplatinum Compounds - adverse effects | Lymphopenia - chemically induced | Enzymes | Medical colleges | Care and treatment | Metastasis | Antineoplastic agents | Cells | Antimitotic agents | Cancer patients | Chemotherapy | Pancreatic cancer | Physiological aspects | Product development | Cancer
Journal Article
British journal of haematology, ISSN 0007-1048, 2018, Volume 180, Issue 5, pp. 666 - 679
Journal Article
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2017, Volume 146, Issue 2, pp. 386 - 391
Abstract Objectives Women with ovarian cancer can have long overall survival and goals of treatment change over time from cure to remission to stable disease.... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Peripheral Nervous System Diseases - chemically induced | Diarrhea - psychology | Nausea - chemically induced | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Fatigue - chemically induced | Pain - chemically induced | Diarrhea - chemically induced | Arthralgia - chemically induced | Gastroesophageal Reflux - chemically induced | Nausea - psychology | Alopecia - psychology | Young Adult | Constipation - psychology | Patient Care Planning | Sexual Dysfunction, Physiological - psychology | Antineoplastic Agents - adverse effects | Adult | Female | Surveys and Questionnaires | Neoplasm Recurrence, Local - psychology | Survivors - psychology | Gastroesophageal Reflux - psychology | Ovarian Neoplasms - drug therapy | Arthralgia - psychology | Ovarian Neoplasms - psychology | Memory Disorders - psychology | Attitude to Health | Peripheral Nervous System Diseases - psychology | Fatigue - psychology | Sexual Dysfunction, Physiological - chemically induced | Drug-Related Side Effects and Adverse Reactions - etiology | Hospitalization | Remission Induction | Constipation - chemically induced | Vomiting - chemically induced | Pain - psychology | Adolescent | Vomiting - psychology | Quality of Life | Alopecia - chemically induced | Aged | Neoplasm Staging | Drug-Related Side Effects and Adverse Reactions - psychology | Memory Disorders - chemically induced | Complications and side effects | Ovarian cancer | Index Medicus
Journal Article
Mayo Clinic proceedings, ISSN 0025-6196, 2012, Volume 87, Issue 8, pp. 732 - 738
Journal Article
Nature protocols, ISSN 1750-2799, 2017, Volume 12, Issue 7, pp. 1295 - 1309
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2013, Volume 31, Issue 5, pp. 616 - 622
Journal Article